They warn that Pfizer vaccine cannot be given to people with a significant history of allergies



[ad_1]

People with history of major allergic reactions They should not receive the Covid-19 vaccine, authorities of the United Kingdom’s National Health Service (NHS) warned on Tuesday, after two members of medical personnel will present discomfort after the first day of vaccinations with the drug developed by Pfizer.

“Last night we saw two cases of allergic reactions. We know from very large clinical trials that this was not a feature, “said June Raine, executive director of the Medicines and Healthcare Products Regulatory Agency (MHRA), adding that now that this experience is available in vulnerable populations, Groups that have been selected as a priority will immediately receive this warning.

“Anyone with a history of a significant allergic reaction to a vaccine, drug, or food (such as a prior history of anaphylactoid reaction or those who have been recommended to carry an adrenaline auto-injector) should not receive the Pfizer / BioNtech vaccine, ”notes the MHRA.

So now the Pfizer / BioNTech vaccine patient information leaflet advises that the drug it should not be administered to allergy sufferers.

“Signs of an allergic reaction can include itchy rash, shortness of breath, and swelling of the face or tongue”Says the brochure.

“The facilities of revival must be available at all times for all vaccinations. Vaccination should only be carried out in facilities where these measures are available “, warns the NHS.

The NHS workers were said to develop symptoms of an “anaphylactoid reaction” shortly after receiving the vaccine and both recovered after appropriate treatment.

Remember that the vaccine is administered in two doses, 21 days apart. People over 80 years of age, their caregivers and health personnel are the first designated to be vaccinated.

In Chile, Pfizer is expected to ship 1.6 million doses in the first quarter of 2021, with 550 thousand doses per month later, and a total of 15 months. In global terms, Pfizer expects to produce 50 million doses this year and 1.3 billion in 2021.

[ad_2]